Stock screenerAll disclosures →
EDGAR →
CELC
Conviction 34HealthcareScan · Thu, Jun 25, 2026CELC$96.09-0.30%
ResistanceSupportVol 14Insider sell7
Vol MA14 1.43M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price96.09
Change-0.30%
Gap-1.09%
Rel volume1.34×
Avg volume1.97M
Avg $ vol185.7M
SMA 2095.91
SMA 50115.84
SMA 20098.11
Price vs 50-17.05%
Price vs 200-2.06%
MA stackmixed
50/200 cross—
Supertrenddown · 107.44
RSI (14)43
MACD hist1.38
MACD crossbull · 2d
Stoch %K / %D72 / 75
ADX (14)32
+DI / −DI20 / 24
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.39%
ADR %6.88%
52w high144.98
52w low11.85
From 52w high-33.72%
Above 52w low+710.89%
New 52w highNo
SqueezeOff
Bollinger width59.19%
%B0.50
Donchian pos25.82%
Donchian high134.97
Donchian low82.55
AVWAP (52w high)108.86
vs AVWAP high-11.73%
AVWAP (52w low)81.37
vs AVWAP low+18.08%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d1.34×
Avg vol (14d)1.43M
Avg vol (20d)1.97M
Avg $ vol (20d)185.7M
Market cap4.69B
RS 3m (vs SPY)-17.78%
RS 6m (vs SPY)-12.46%
RS line new highNo
Trend template4/8
Technical rank26.6
1 week+9.13%
1 month-28.43%
3 months-12.82%
6 months-4.99%
1 year+690.86%
YTD-4.44%
P/E-26.47
P/B87.55
P/S—
P/FCF-30.52
EPS-3.79
Div yield—
ROE-330.77%
ROA-43.16%
Debt/Eq2.58
Current12.31
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-58.39%
Price target163.00
Target upside69.63%
Analyst ratingBuy
Institutional105.60%
Ent. value4.68B
Revenue—
Net income-52.84M
Gross profit—
Free cash flow-153.53M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out48.77M
Employees155
ListedWed, Sep 20, 2017
Free float34.78M
Float %75.2%
Short interest9.6M
Days to cover12.1d
Short volume64.5%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.97 vs −$1.07
Last surprise+9.3% beat
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank26.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance146.92
Support83.16
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CELC
No recent disclosed trades by Congress in CELC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CELC · 7 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Murphy Polly A. Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Furcht Leo Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
ROMP CHARLES R Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Buller Richard E Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Buller Richard E Director · Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
NIGON RICHARD Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Dalvey David Director · Common Stock · 2026-06-05 | Grant | 1.53K | $0 | 2026-06-05 | 2026-06-09 |
Dalvey David Director · Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
Laing Lance G. Chief Science Officer · Common Stock · 2026-06-02 | Exercise | 1K | $10K | 2026-06-02 | 2026-06-04 |
Laing Lance G. Chief Science Officer · Stock Option (right to buy) · 2026-06-02 | Exercise | 1K | $0 | 2026-06-02 | 2026-06-04 |
SEC filings
EDGAR filings in CELC · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.